We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Identifies and Stratifies Risk Posed by Lung Nodules

By HospiMedica International staff writers
Posted on 22 Apr 2013
A multidisciplinary group of researchers has devised a new software tool that noninvasively characterizes pulmonary adenocarcinoma, a common type of cancerous nodule in the lungs. More...


The pilot study’s findings of the computer-aided nodule assessment and risk yield (CANARY) were published April 2013 in the Journal of Thoracic Oncology. “Pulmonary adenocarcinoma is the most common type of lung cancer and early detection using traditional computed tomography [CT] scans can lead to a better prognosis,” said Tobias Peikert, MD, a Mayo Clinic (Rochester, MN, USA) pulmonologist and senior author of the study. “However, a subgroup of the detected adenocarcinomas identified by CT may grow very slowly and may be treatable with less extensive surgery.”

CANARY can noninvasively stratify the risk lung adenocarcinomas pose by characterizing the nodule as aggressive or indolent with high-sensitivity, specificity, and predictive values. The software utilizes data gathered from existing high-resolution diagnostic or screening computed tomography (CT) images of pulmonary adenocarcinomas to correlate each pixel of the lung nodule to one of nine unique radiologic exemplars. In testing, the CANARY classification of these lesions had an excellent correlation with the microscopic analysis of the surgically removed lesions that were examined by lung pathologists, according to Dr. Peikert.

“Without effective screening, most lung cancer patients present with advanced stage disease, which has been associated with poor outcomes,” Dr. Peikert said. “While CT lung cancer screening has been shown to improve patient survival, the initiation of a nationwide screening program would carry the risk of overtreatment of slow growing tumors and would be associated with substantial health care costs. CANARY represents a new tool to potentially address these issues.”

Related Links:

Mayo Clinic




New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.